Relay Therapeutics Inc. (RLAY) Social Stream
RELAY THERAPEUTICS INC (RLAY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RLAY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-11 | 5 | $66 | $51 | $57 | $11.38 | 400.88% |
| 2021-11-11 | 5 | $66 | $51 | $56.25 | $11.38 | 394.29% |
| 2021-11-12 | 5 | $54 | $47 | $51.666 | $11.38 | 354.01% |
| 2022-03-03 | 5 | $54 | $45 | $50 | $11.38 | 339.37% |
| 2022-05-06 | 5 | $54 | $45 | $48 | $11.38 | 321.79% |
| 2022-05-10 | 5 | $47 | $35 | $44 | $11.38 | 286.64% |
| 2022-05-24 | 6 | $47 | $35 | $43.666 | $11.38 | 283.71% |
| 2022-06-06 | 7 | $47 | $13 | $39.285 | $11.38 | 245.21% |
| 2022-08-05 | 7 | $47 | $13 | $38 | $11.38 | 233.92% |
| 2022-08-13 | 8 | $47 | $13 | $37.857 | $11.38 | 232.66% |
| 2022-09-02 | 8 | $47 | $13 | $38.125 | $11.38 | 235.02% |
| 2022-09-17 | 9 | $50 | $16 | $39.75 | $11.38 | 249.3% |
| 2022-09-30 | 10 | $50 | $16 | $37.888 | $11.38 | 232.93% |
| 2022-10-07 | 10 | $50 | $16 | $37.666 | $11.38 | 230.98% |
| 2022-11-07 | 10 | $50 | $16 | $37.444 | $11.38 | 229.03% |
| 2022-12-20 | 10 | $45 | $16 | $36.666 | $11.38 | 222.2% |
| 2023-01-27 | 10 | $45 | $16 | $34.375 | $11.38 | 202.07% |
| 2023-02-08 | 10 | $45 | $16 | $34.222 | $11.38 | 200.72% |
| 2023-02-24 | 10 | $45 | $16 | $33.555 | $11.38 | 194.86% |
| 2023-03-07 | 10 | $46 | $16 | $33.888 | $11.38 | 197.79% |
| 2023-03-09 | 10 | $46 | $16 | $33.3 | $11.38 | 192.62% |
| 2023-04-11 | 10 | $46 | $16 | $33 | $11.38 | 189.98% |
| 2023-04-18 | 11 | $46 | $16 | $32.636 | $11.38 | 186.78% |
| 2023-04-19 | 11 | $46 | $16 | $32.636 | $11.38 | 186.78% |
| 2023-05-04 | 11 | $46 | $12.5 | $30.045 | $11.38 | 164.02% |
| 2023-05-05 | 11 | $46 | $12.5 | $29.409 | $11.38 | 158.43% |
| 2023-06-06 | 10 | $46 | $12.5 | $28.15 | $11.38 | 147.36% |
| 2023-06-11 | 11 | $33 | $12.5 | $26.75 | $11.38 | 135.06% |
| 2023-08-09 | 11 | $33 | $12.5 | $25.954 | $11.38 | 128.07% |
| 2023-10-12 | 11 | $33 | $12.5 | $25.772 | $11.38 | 126.47% |
| 2023-10-13 | 11 | $33 | $9.4 | $25.49 | $11.38 | 123.99% |
| 2023-11-03 | 11 | $33 | $9.4 | $25.036 | $11.38 | 120% |
| 2023-11-09 | 12 | $33 | $9.4 | $23.309 | $11.38 | 104.82% |
| 2023-12-11 | 11 | $33 | $9.4 | $23.036 | $11.38 | 102.43% |
The Trend in the Analyst Price Target
RLAY's average price target has moved down $31.36 over the prior 29 months.
Over the past 47 weeks, RLAY's average upside potential has been 147.23%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 10 | 45 | 16.0 | 34.222 | 20.37 | 68% |
| 2023-03-09 | 10 | 46 | 16.0 | 33.300 | 15.57 | 113.87% |
| 2023-04-19 | 11 | 46 | 16.0 | 32.636 | 12.35 | 164.26% |
| 2023-04-20 | 11 | 46 | 12.5 | 30.045 | 12.47 | 140.94% |
| 2023-05-05 | 11 | 46 | 12.5 | 28.150 | 11.27 | 149.78% |
RLAY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 9 | 0 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
RLAY's average broker recommendation rating worsened by 0.36 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RLAY has a higher upside potential (average analyst target price relative to current price) than 3997.6% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, RELAY THERAPEUTICS INC's variance in analysts' estimates is lower than -3145.57% of them.
- RLAY has a higher number of analysts covering the stock than 2771.43% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, RELAY THERAPEUTICS INC's average analyst price target is greater than 2641.75% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RELAY THERAPEUTICS INC are ALVR, KYMR, and CCCC.
View All Top Stocks by Price Target
Make investment decisions regarding RLAY using the data that counts. Try POWR Ratings for free.